517 related articles for article (PubMed ID: 9730425)
21. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
[TBL] [Abstract][Full Text] [Related]
22. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study.
Imamović G; Zerem E; Osmanović E
Eur J Intern Med; 2010 Dec; 21(6):524-9. PubMed ID: 21111938
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
Halloran P; Mathew T; Tomlanovich S; Groth C; Hooftman L; Barker C
Transplantation; 1997 Jan; 63(1):39-47. PubMed ID: 9000658
[TBL] [Abstract][Full Text] [Related]
25. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
[TBL] [Abstract][Full Text] [Related]
26. Optimization of the immunosuppressive protocol after lung transplantation.
Reichenspurner H; Kur F; Treede H; Meiser BM; Deutsch O; Welz A; Vogelmeier C; Schwaiblmair M; Müller C; Fürst H; Briegel J; Reichart B
Transplantation; 1999 Jul; 68(1):67-71. PubMed ID: 10428269
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
Hamour IM; Lyster HS; Burke MM; Rose ML; Banner NR
Transplantation; 2007 Mar; 83(5):570-6. PubMed ID: 17353776
[TBL] [Abstract][Full Text] [Related]
28. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
[TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
30. Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
Cransberg K; Marlies Cornelissen EA; Davin JC; Van Hoeck KJ; Lilien MR; Stijnen T; Nauta J
Pediatr Transplant; 2005 Feb; 9(1):104-11. PubMed ID: 15667622
[TBL] [Abstract][Full Text] [Related]
31. Effect of mycophenolate mofetil in heart transplantation.
Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
[TBL] [Abstract][Full Text] [Related]
32. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
[TBL] [Abstract][Full Text] [Related]
34. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
35. Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
Ross DJ; Jordan SC; Nathan SD; Kass RM; Koerner SK
Chest; 1996 Apr; 109(4):870-3. PubMed ID: 8635362
[TBL] [Abstract][Full Text] [Related]
36. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
[TBL] [Abstract][Full Text] [Related]
37. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
38. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
[TBL] [Abstract][Full Text] [Related]
39. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
40. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
Oh JM; Wiland AM; Klassen DK; Weidle PJ; Bartlett ST
J Clin Pharmacol; 2001 Aug; 41(8):861-9. PubMed ID: 11504274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]